Dr. Ashish Bagai

Dr. Ashish Bagai serves as a key procurement leader within the Defense Advanced Research Projects Agency (DARPA), driving the acquisition of high-risk, high-reward research and development initiatives aligned with the agency’s mission to enable transformative military technologies. He oversees the solicitation and award of contracts for cutting-edge scientific innovation across physical, engineering, and life sciences, with a focus on accelerating breakthroughs in autonomous systems, next-generation computing, bio-integrated platforms, and advanced materials. His procurement activities are mission-critical to DARPA’s programmatic efforts, including initiatives such as VITAL, PICASSO, and O-CIRCUI, ensuring rapid transition of novel technologies from lab to field. Dr. Bagai maintains strategic partnerships with a select group of elite research and technology providers, including AEROSPACE & COMMERCIAL TECHNOLOGIES, LLC, AMD INTERNATIONAL TECHNOLOGIES LLC, SYSTEMS & TECHNOLOGY RESEARCH LLC, and ABBOTT LABORATORIES INC. These relationships reflect a preference for industry leaders and specialized R&D firms capable of delivering complex, multidisciplinary solutions under aggressive timelines. His contracting approach emphasizes technical excellence, agility, and innovation capacity over volume, fostering collaborative, performance-driven engagements with vendors possessing deep domain expertise. Dr. Bagai’s procurement portfolio is entirely open competition, with no set-asides designated under 8(a), HUBZone, SDVOSB, or other socioeconomic categories. This reflects DARPA’s priority for technical capability and mission readiness over socioeconomic preferences, ensuring that the most qualified entities—regardless of size or certification—are selected based on scientific merit and execution readiness. His primary focus is on NAICS 541712, encompassing research and development in the physical, engineering, and life sciences. He procures advanced prototypes, experimental systems, sensor technologies, and bio-integrated hardware, targeting institutions and firms with proven capabilities in materials science, neuroengineering, quantum computing, and autonomous control architectures. His expertise lies in navigating the intersection of federal R&D funding and high-technology innovation procurement.